Association of glutathione S-transferase M1 (GSTM1) null genotype polymorphism with the effectiveness of metformin monotherapy in type 2 diabetes mellitus (T2DM) patients
Abstract
Genetic variations may contribute to the development of diabetes and influence individual susceptibility to the disease. One of the relevant genes is glutathione S-transferase M1 (GSTM1). Alterations in the expression of GST enzymes can lead to inefficient detoxification processes. Such genetic variations are believed to contribute to interindividual variability in metformin response, potentially affecting therapeutic outcomes. This study aimed to evaluate the effect of the GSTM1 null genotype on the effectiveness of metformin monotherapy in patients with type 2 diabetes mellitus (T2DM). This was an observational study with a case–control design. The case group consisted of T2DM patients who failed to achieve the target HbA1c level. Detection of the GSTM1 null genotype was performed using polymerase chain reaction (PCR). The association between GSTM1 genotype and the effectiveness of metformin was analyzed using the Chi-square test. Disease risk associated with the genetic polymorphism was assessed by calculating the odds ratio (OR) and 95% confidence interval (CI). There was no significant association between GSTM1 genotype groups and the effectiveness of metformin monotherapy (OR = 0.487; p = 0.318). In conclusion, the GSTM1 null genotype does not significantly influence the therapeutic effectiveness of metformin monotherapy in patients with T2DM.
References
Bailey CJ. Metformin: Historical overview. Diabetologia 2017; 60(9):1566-76.
https://doi.org/10.1007/s00125-017-4318-z
Stoian A, Bacarea A, Motataianu A, Stoinen M, Gliga F, Bacarea V, et al, Vascular endothelial growth factor insertion/deletion gene polymorphism in patients with type 2 diabetes and diabetic peripheral polyneuropathy. Revista Romana de Medicina de Laborator 2014; 22(2):165-72.
https://doi.org/10.2478/rrlm-2014-0023
Aouacheri O, Saka S, Krim M, Messaadia A, Maidi I. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus. Can J Diabetes 2015; 39(1):44-9.
https://doi.org/10.1016/j.jcjd.2014.03.002
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes and the metabolic syndrome. J Clin Invest 2006; 116(7):1784-92.
https://doi.org/10.1172/JCI29126
Amer MA, Ghattas MH, Abo-ElMatty DM, Abou-El-Ela SH. Influence of glutathione S-transferase polymorphisms on type-2 diabetes mellitus risk. Genet Mol Res 2011; 10(4):3722-30.
https://doi.org/10.4238/2011.October.31.14
Banerjee M, Vats P. Reactive metabolites and antioxidant gene polymorphisms in type 2 diabetes mellitus. Redox Biol 2014; 2:170-7.
https://doi.org/10.1016/j.redox.2013.12.001
Baziad A. Polymorphism. Indonesian Gynecology Major Obstet 2007; 31(2):116-20.
Geisler SA, Olshan AF. GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 2001; 154(2):95-105.
https://doi.org/10.1093/aje/154.2.95
Kalkan IH, Suher M. The relationship between the level of glutathione, impairment of glucose metabolism and complications of diabetes mellitus. Pak J Med Sci 2013; 29(4):938-42.
https://doi.org/10.12669/pjms.294.2859
Pinheiro DS, Rocha Filho CR, Mundim CA, de Marco Junior P, Ulhoa CJ, Reis AA, et al. Evaluation of glutathione S-transferase GSTM1 and GSTT1 deletion polymorphisms on type-2 diabetes mellitus risk. PLoS One 2013; 8(10):e76262.
https://doi.org/10.1371/journal.pone.0076262
Ellegren H. Microsatellites: simple sequences with complex evolution. Nat Rev Genet, 2004; 5(6):435-45.
https://doi.org/10.1038/nrg1348
Rasheed MN, Hasan OM, Mahmood AS. Association of Glutathione S-Transferase (GSTM1, T1) Gene Polymorphisms with Type 2 Diabetes Mellitus (T2DM) in the Iraqi Patients. Iraqi J Biotechnol 2015; 14(1):70-6.
Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res 2001; 482(1–2):21–6.
https://doi.org/10.1016/s0027-5107(01)00206-8
Yalin S, Hatungil R, Tamer L, Ates NA, Dogruer N, Yildirim H, et al. Glutathione S-transferase gene polymorphisms in Turkish patients with diabetes mellitus. Cell Biochem Funct 2007; 25(5):509-13.
https://doi.org/10.1002/cbf.1339
Wang G, Zhang L, Li Q. Genetic polymorphisms of GSTT1, GSTM1, and NQO1 genes and diabetes mellitus risk in Chinese population. Biochemical Biophys Res Commun 2006; 341(2):310-3.
https://doi.org/10.1016/j.bbrc.2005.12.195
Suresh Lal. Diabetes: Causes, Symptoms And Treatments. 2016. Public Health Environment and Social Issues in India (pp. 55-67). Edition: 1. Chapter: 5. Publisher: Serials Publication.
https://www.Researchgate.Net/Publication/311562631
Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world—a growing challenge. N Engl J Med 2007; 356(3):213-5.
https://doi.org/10.1056/NEJMp068177
Francis J, Raghunathan S, Khanna P. The role of genetics in stroke. Postgrad Med J 2007; 83(983):590-5.
https://doi.org/10.1136/pgmj.2007.060319
Sterne J. The long journey of metformin. Ethical Digest 2007; 37:21.
Paneni F, Lüscher TF. Cardiovascular protection in the treatment of type 2 diabetes: a review of clinical trial results across drug classes. Am J Cardiol 2017; 120(1S):S17-27.
https://doi.org/10.1016/j.amjcard.2017.05.015
Sanchez-Rangell E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia 2017; 60(9):1586-93.
https://doi.org/10.1007/s00125-017-4336-x
Sumampouw HC, Halim S. Correlation of glycemic status with lipid profile in type 2 diabetes mellitus patients at Sumber Waras Hospital and Hermina Kemayoran Hospital 2015-2017. Tarumanagara Med J 2019; 1(2):319-28.
https://doi.org/10.24912/tmj.v1i2.3852
Dita Virginia. Pengaruh variasi genetik PRKAA2 terhadap efektifitas terapi metformin dan risiko penyakit kardiovaskular pada pasien diabetes mellitus tipe 2 di Kabupaten Sleman, Daerah Istimewa Yogyakarta. [Disertasi]: Yogyakarta: Universitas Gadjah Mada, 2021.
Sheikhha MH, Kalantar Ml, Khalid Tobal KH, Yin JAL. Glutathione S-transferases null genotype in acute myeloid leukemia. IJI 2005; 2(3):141-51.
Sheehan D, Meade G, Foley VM, Dowd CA. Structure, function and evolution of glutathione transferases: Implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 2001; 360(Pt 1):1-16.
https://doi.org/10.1042/0264-6021:3600001
Indonesian Endocrinology Association (PERKENI). Consensus on management and prevention of type 2 diabetes mellitus in Indonesia. Jakarta: PERKENI, 2015.
Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009; 361(12):1152-63.
https://doi.org/10.1056/NEJMoa0804381
Jehan T, Lakhanpaul S. Single nucleotide polymorphism (SNP)–methods and applications in plant genetics: a review. Indian J Biotechnol 2006; 5(4):435-59.
Rahimi-Madiseh M, Malekpour-Tehrani A, Bahmani M, Rafieian-Kopaei M. The research and development on the antioxidants in prevention of diabetic complications. Asian Pac J Trop Med 2016; 9(9):825-31.
https://doi.org/10.1016/j.apjtm.2016.07.001
Park YJ, Lee JK, Kim NS. Simple sequence repeat polymorphisms (SSRPs) for evaluation of molecular diversity and germplasm classification of minor crops. Molecules 2009; 14(11):4546-69.
https://doi.org/10.3390/Molecules14114546
Kirk BW, Feinsod M, Favis R, Kleiman RM, Barany F. Single nucleotide polymorphism seeking long-term association with complex disease. Nucleic Acids Res 2002; 30(15):3295-311.
https://doi.org/10.1093/nar/gkf466
Lexis CP, Wieringa WG, Hiemstra B, van Deursen VM, Lipsic E, van der Harst P, et al. Chronic metformin treatment is associated with reduced myocardial infarct size in diabetic patients with ST-segment elevation myocardial infarction. Cardiovasc Drugs Ther 2014; 28(2):163-71.
